Boehringer Ingelheim (Germany) forms new company:
This article was originally published in Clinica
Executive Summary
Boehringer Ingelheim (Germany) has merged certain bioproducts businesses to form a separate company, Boehringer Ingelheim Bioproducts Partnership. Focusing on in vitro diagnostics and bioproducts, it will be based in Heidelberg. The new company comprises Serva Feinbiochemica (Germany), Bender MedSystems (Austria), Boehringer Ingelheim-BioWhittaker Partnership (Belgium) and BioWhittaker (France). Ingelheim Diagnostica y Tecnologia (Spain) will be incorporated during 1997. Sales of the new company are expected to reach DM 70 million ($48 million) in 1996.